安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Eikon Therapeutics
Eikon is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs We are passionate about novel therapeutics and share the belief that a better understanding of fundamental human disease biology can lead to better medicines
- Eikon Therapeutics, Inc. (EIKN) Stock Price, News, Quote History . . .
Find the latest Eikon Therapeutics, Inc (EIKN) stock quote, history, news and other vital information to help you with your stock trading and investing
- Eikon Therapeutics (EIKN) Stock Price Overview
A detailed overview of Eikon Therapeutics, Inc (EIKN) stock, including real-time price, chart, key statistics, news, and more
- Eikon upsized $381M listing marks largest biotech IPO since 2024
Eikon Therapeutics is heading to the Nasdaq this morning with an upsized $381 million IPO in a further sign of the renewed appeal of the public markets
- Merck veteran Perlmutter-led Eikon Therapeutics eyes $908 million . . .
Eikon, founded in 2019 by Chemistry Nobel prize winner Eric Betzig, Xavier Darzacq, Luke Lavis, and Robert Tjian, is developing a potential treatment pipeline for various types of cancers
- Eikon Therapeutics - LinkedIn
Our clinical programs in oncology leverage immune response modulation and synthetic lethality to improve cancer therapy, while our discovery efforts are focused on identifying novel targets through
- Well-funded Bay Area biotech company lays off 55, blames Trump admin
Eikon Therapeutics, a well-funded Bay Area biotech startup working to develop both drugs and a lab tool for other researchers, is laying off dozens of employees — and pointing blame at the
- EIKN Stock Price Quote | Morningstar
See the latest Eikon Therapeutics Inc stock price (EIKN:XNAS), related news, valuation, dividends and more to help you make your investing decisions
|
|
|